Resound Nexia Expert Review

The Resound Nexia is a premium behind-the-ear prescription hearing aid released in 2023, currently available at $4,298. In HearAdvisor's lab testing, it earns a B grade with a SoundScore of 3.8/5, placing it in the middle tier of the prescription hearing aid category.

The Nexia demonstrates notable strengths in several areas. Speech clarity in quiet environments scores a solid 3.8/5, measuring 0.37 points above the category average. Own-voice comfort is another highlight at 3.6/5, sitting 0.85 points above average—a meaningful advantage for wearers sensitive to how their own voice sounds. Feedback handling is excellent at 5.0/5, ensuring stability during movement and physical contact with the devices.

However, the Nexia shows a significant limitation in noisy environments. Speech-in-noise performance scores just 0.4/5, falling 1.15 points below the category average. This represents a substantial gap compared to top-performing competitors in the same price tier. Music streaming quality is mixed at 2.8/5, slightly above average but modest in absolute terms.

At this price point, several alternatives deliver stronger overall performance, including the Oticon Intent (4.75/5) and Phonak Sphere Infinio (4.65/5). The Nexia may suit listeners who prioritize conversation in quieter settings and value excellent feedback control, but those frequently navigating challenging acoustic environments should consider higher-scoring options.